[["Map",1,2,9,10,90,91,584,585],"meta::meta",["Map",3,4,5,6,7,8],"astro-version","5.14.6","content-config-digest","f6010e485d176744","astro-config-digest","{\"root\":{},\"srcDir\":{},\"publicDir\":{},\"outDir\":{},\"cacheDir\":{},\"site\":\"https://sklasfeld.github.io\",\"compressHTML\":true,\"base\":\"/\",\"trailingSlash\":\"ignore\",\"output\":\"static\",\"scopedStyleStrategy\":\"attribute\",\"build\":{\"format\":\"directory\",\"client\":{},\"server\":{},\"assets\":\"_astro\",\"serverEntry\":\"entry.mjs\",\"redirects\":true,\"inlineStylesheets\":\"auto\",\"concurrency\":1},\"server\":{\"open\":false,\"host\":false,\"port\":4321,\"streaming\":true,\"allowedHosts\":[]},\"redirects\":{},\"image\":{\"endpoint\":{\"route\":\"/_image\"},\"service\":{\"entrypoint\":\"astro/assets/services/sharp\",\"config\":{}},\"domains\":[],\"remotePatterns\":[],\"responsiveStyles\":false},\"devToolbar\":{\"enabled\":true},\"markdown\":{\"syntaxHighlight\":false,\"shikiConfig\":{\"langs\":[],\"langAlias\":{},\"theme\":\"github-dark\",\"themes\":{},\"wrap\":false,\"transformers\":[]},\"remarkPlugins\":[null],\"rehypePlugins\":[[null,{}]],\"remarkRehype\":{},\"gfm\":true,\"smartypants\":true},\"security\":{\"checkOrigin\":true,\"allowedDomains\":[]},\"env\":{\"schema\":{},\"validateSecrets\":false},\"experimental\":{\"clientPrerender\":false,\"contentIntellisense\":false,\"headingIdCompat\":false,\"preserveScriptOrder\":false,\"liveContentCollections\":false,\"csp\":false,\"staticImportMetaEnv\":false,\"chromeDevtoolsWorkspace\":false,\"failOnPrerenderConflict\":false},\"legacy\":{\"collections\":false}}","blog",["Map",11,12,63,64],"20250901-genomics-diversity-crisis",{"id":11,"data":13,"body":31,"filePath":32,"digest":33,"rendered":34},{"title":14,"excerpt":15,"publishDate":16,"isFeatured":17,"tags":18,"seo":26},"The Genomics Diversity Crisis","When 86% of genomic data comes from European ancestry, treatments built on this data will inevitably fail marginalized communities.",["Date","2025-09-01T04:00:00.000Z"],false,[19,20,21,22,23,24,25],"diversity-equity-inclusion","dei-in-science","inclusive-research","genetics","equity-in-science","diversity-in-stem","genomics-equity",{"image":27,"pageType":30},{"src":28,"alt":29},"/ehimetalor-akhere-unuabona-Hf4QOGcnBnA-unsplash.jpg","Photo of a Respect my HIV protest in London","website","\u003Cfigure> \n  \u003Cimg src=\"/ehimetalor-akhere-unuabona-Hf4QOGcnBnA-unsplash.jpg\" alt=\"Photo of a Respect my HIV protest in London\">\n  \u003Cfigcaption>\u003Cem>Recent studies on HIV included scientists from communities affected by HIV as an effort to improve ethical standards of this research. Photo by \u003Ca href=\"https://unsplash.com/@mettyunuabona?utm_source=unsplash&utm_medium=referral&utm_content=creditCopyText\">Ehimetalor Akhere Unuabona\u003C/a> on \u003Ca href=\"https://unsplash.com/photos/a-group-of-people-marching-down-a-street-holding-a-sign-Hf4QOGcnBnA?utm_source=unsplash&utm_medium=referral&utm_content=creditCopyText\">Unsplash\u003C/a>.\u003C/em>\u003C/figcaption>\n\u003C/figure>\n\nAs diversity, equity, and inclusion (DEI) initiatives are being dismantled across US institutions, Eric Green, former Director of the National Human Genome Research Institute, opened the Festival of Genomics in Boston to make a case that DEI extends far beyond creating a better workplace culture. In genomics research, DEI is scientifically essential. DEI refers to efforts that ensure diverse representation (diversity) through fair treatment and opportunity (equity) and meaningful participation (inclusion), all grounded in respect for different communities and perspectives. Current genomic datasets overwhelmingly represent people of European ancestry, yet the insights derived from this narrow slice of humanity are being applied to diagnose, treat, and understand disease across all populations. To truly reflect human diversity, science depends on data from all communities. However, that data cannot be collected from populations who distrust the scientific establishment. Genuine commitments to equity and inclusion are the foundation needed to rebuild those critical relationships.\n\n### The Technical Problem: Sampling Bias\n\nSampling bias is a fundamental challenge at the heart of genomics research. This occurs when data used to build a model fails to adequately represent the study or target population due to the underrepresentation of certain groups. A classic example of sampling bias would be trying to understand human height by collecting data only from NBA players. The resulting model would drastically overestimate how tall humans are. Since sampling bias compromises generalizability, these models often produce misleading outputs. In genomics, sampling bias can lead researchers to overestimate or underestimate impacts of genetic variants or treatments.\n\nIn the field of genomics, the risk of sampling bias takes on particular urgency. In 2021, an estimated 86% of sequenced genomic data came from individuals of European ancestry [^1]. This staggering imbalance means that models trained on this data are systematically misleading and, therefore, unreliable across diverse populations. This is a profound problem because models that fail to generalize to marginalized communities will inevitably exacerbate existing health disparities.\n\nAs bioinformatics enters a new era of artificial intelligence (AI) driven discovery, the composition of our training data has never mattered more. How can we build a future of personalized medicine on a foundation that only represents less than 20% of the world's population?\n\n### The Human Problem: A Legacy of Distrust\n\nTo improve our biological models, we must prioritize diverse dataset collection. However, while the solution seems straightforward, the reality is far more complex. The scientific community's painful history of human exploitation and data misuse continues to stifle many communities' willingness to participate in research studies.\n\nThese scars run deep. From 1932 to 1972, with support from state and local governments, the US Public Health Service conducted what became known as the Tuskegee Syphilis Study, misleading impoverished Black male sharecroppers to participate in a treatment program for their \"bad blood\" [^2], [^3]. In reality, the program was a study of the progression of untreated syphilis. Withheld from diagnoses and available treatment, hundreds of participants lost their lives from the disease in the name of scientific advancement.\n\nEven well-intentioned research can have ethical missteps that deepen distrust. In the 1990s, as the rate of diabetes climbed in the Havasupai tribe, an indigenous community near the Grand Canyon, around 650 members donated blood samples to Arizona State University to study genetic links to diabetes [^4]. Approximately a hundred participants signed a consent form allowing their samples to be used to \"study the causes of behavior/medical disorders.\" However, with English as a second language for many participants and most having never completed high school, the full implications of this broad consent were at high risk of not being understood. Therefore, when researchers used the tribe's samples in studies unrelated to diabetes, it was done with disregard to the civil rights of the Havasupai tribe to self-determination. Rightfully, the Havasupai tribe sued the university and has refused to participate in any further studies.\n\nMore recently, the rise of consumer genetic testing, such as those offered by 23andMe, has made it easy to share genetic data. However, these platforms have also raised concerns about data transparency for marginalized communities [^5]. These companies tell consumers that consumers own their personal data. However, for communities who are already wary of government surveillance and over-policing, the knowledge that their genetic information could potentially be sold to pharmaceutical companies to develop medicine that they will not have access to or accessed by law enforcement in ways that could lead to wrongful convictions for them or a family member adds another layer of hesitation to research participation.\n\nThe examples listed only touch the surface of these deeply rooted issues that plague distrust of the scientific community, and I encourage readers to learn more outside the context of this article.\n\n### A Path Forward: DEI as a Framework for Rebuilding Trust\n\nHistory shows that trust in science, even after profound breaches, can be rebuilt. The atrocities conducted by medical professionals in the Holocaust ruptured the relationship between science and Jewish communities [^6]. Despite this history, today the Ashkenazi Jewish population is among the most studied groups in human genomics. This reconciliation was made possible through decades of ethical reform and intentional efforts to include and support Jewish scientists.\n\nThe Nuremberg Code, a framework established in response to unethical Nazi medical experiments, set up crucial protections for research participants through informed consent and participant autonomy [^7]. However, while these protections support equitable practices, they did not insure participants have meaningful representation and decision-making power in the research itself. For the Jewish community, this gap was filled by inclusive practices like the Rockefeller Foundation's Refugee Scholar Program, which resettled Jewish scientists and supported their continued involvement in research despite widespread persecution [^8]. This combination of ethical frameworks and institutional inclusion likely contributed significantly to rebuilding trust between Jewish communities and scientific institutions.\n\nUntil recently, we were seeing similar patterns emerging through initiatives of inclusion. Researchers from communities affected by HIV/AIDS has been associated with improved rates of community engagement in research and better treatment outcomes [^9]. Similarly, Indigenous health research programs indicate that studies of their communities benefit from Indigenous leadership by increasing community engagement and fostering resources to support non-Indigenous research team members to develop cultural competency [^10]. These studies ensured that voices of the communities they were doing research on were empowered to shape the research process, from study design to data interpretation.\n\nIt must be emphasized that practicing DEI is not a quick fix. DEI practices must be sustained, proactive commitments to ensure diversity through informed consent and inclusion. As genomics continues to evolve, so must our standards for how research is conducted, whose data is included, and how the data is used. By building trust, we build better science and, in turn, better health outcomes for everyone.\n\nAs we stand at the threshold of AI-driven genomics, we have a choice to make. We can continue building models on a narrow foundation that serves only a fraction of humanity, or we can invest in the trust-building work necessary to create truly inclusive research. The technical quality of our science depends on our decision.\n\n### References:\n\n[^1]: Fatumo, S., Chikowore, T., Choudhury, A., Ayub, M., Martin, A. R., & KuchenbÃ¤cker, K. (2022). Diversity in genomic studies: a roadmap to address the imbalance. Nature medicine, 28(2), 243.\n\n[^2]: Jones, J. H. (1993). Bad blood: the Tuskegee syphilis experiment. New and expanded ed. New York.\n\n[^3]: Gray, F. (1998). The Tuskegee syphilis study: An insiderâ€™s account. Montgomery, AL: Black Belt.\n\n[^4]: Sterling, R. L. (2011). Genetic research among the Havasupai: a cautionary tale. AMA Journal of Ethics, 13(2), 113-117.\n\n[^5]: Raz, A. E., Niemiec, E., Howard, H. C., Sterckx, S., Cockbain, J., & Prainsack, B. (2020). Transparency, consent and trust in the use of customers' data by an online genetic testing company: an exploratory survey among 23andMe users. New Genetics and Society, 39(4), 459-482.\n\n[^6]: Lagnado, L. M., & Dekel, S. C. (1992). Children of the flames: Dr. Josef Mengele and the untold story of the twins of Auschwitz. Penguin.\n\n[^7]: Trials of War Criminals before the Nuremberg Military Tribunals under Control Council Law No. 10. (n.d.). Permissible medical experiments. (Vol. 2, pp. 181-182). Washington, D.C.: U.S. Government Printing Office.\n\n[^8]: Iacobelli, T. (2021). The Rockefeller Foundationâ€™s Refugee Scholar Program.\n\n[^9]: Karris, M. Y., Dube, K., & Moore, A. A. (2020). What lessons it might teach us? Community engagement in HIV research. Current Opinion in HIV and AIDS, 15(2), 142-149.\n\n[^10]: Woods, C., Settee, C., Beaucage, M., Robinson-Settee, H., Desjarlais, A., Adams, E., ... & Nahanee, D. (2023). Ensuring Indigenous co-leadership in health research: a Can-SOLVE CKD case example. International Journal for Equity in Health, 22(1), 234.","src/content/blog/20250901-genomics-diversity-crisis.md","02af336c092b5738",{"html":35,"metadata":36},"\u003Cfigure> \n  \u003Cimg src=\"/ehimetalor-akhere-unuabona-Hf4QOGcnBnA-unsplash.jpg\" alt=\"Photo of a Respect my HIV protest in London\">\n  \u003Cfigcaption>\u003Cem>Recent studies on HIV included scientists from communities affected by HIV as an effort to improve ethical standards of this research. Photo by \u003Ca href=\"https://unsplash.com/@mettyunuabona?utm_source=unsplash&#x26;utm_medium=referral&#x26;utm_content=creditCopyText\">Ehimetalor Akhere Unuabona\u003C/a> on \u003Ca href=\"https://unsplash.com/photos/a-group-of-people-marching-down-a-street-holding-a-sign-Hf4QOGcnBnA?utm_source=unsplash&#x26;utm_medium=referral&#x26;utm_content=creditCopyText\">Unsplash\u003C/a>.\u003C/em>\u003C/figcaption>\n\u003C/figure>\n\u003Cp>As diversity, equity, and inclusion (DEI) initiatives are being dismantled across US institutions, Eric Green, former Director of the National Human Genome Research Institute, opened the Festival of Genomics in Boston to make a case that DEI extends far beyond creating a better workplace culture. In genomics research, DEI is scientifically essential. DEI refers to efforts that ensure diverse representation (diversity) through fair treatment and opportunity (equity) and meaningful participation (inclusion), all grounded in respect for different communities and perspectives. Current genomic datasets overwhelmingly represent people of European ancestry, yet the insights derived from this narrow slice of humanity are being applied to diagnose, treat, and understand disease across all populations. To truly reflect human diversity, science depends on data from all communities. However, that data cannot be collected from populations who distrust the scientific establishment. Genuine commitments to equity and inclusion are the foundation needed to rebuild those critical relationships.\u003C/p>\n\u003Ch3 id=\"the-technical-problem-sampling-bias\">The Technical Problem: Sampling Bias\u003C/h3>\n\u003Cp>Sampling bias is a fundamental challenge at the heart of genomics research. This occurs when data used to build a model fails to adequately represent the study or target population due to the underrepresentation of certain groups. A classic example of sampling bias would be trying to understand human height by collecting data only from NBA players. The resulting model would drastically overestimate how tall humans are. Since sampling bias compromises generalizability, these models often produce misleading outputs. In genomics, sampling bias can lead researchers to overestimate or underestimate impacts of genetic variants or treatments.\u003C/p>\n\u003Cp>In the field of genomics, the risk of sampling bias takes on particular urgency. In 2021, an estimated 86% of sequenced genomic data came from individuals of European ancestry \u003Csup>\u003Ca href=\"#user-content-fn-1\" id=\"user-content-fnref-1\" data-footnote-ref=\"\" aria-describedby=\"footnote-label\">1\u003C/a>\u003C/sup>. This staggering imbalance means that models trained on this data are systematically misleading and, therefore, unreliable across diverse populations. This is a profound problem because models that fail to generalize to marginalized communities will inevitably exacerbate existing health disparities.\u003C/p>\n\u003Cp>As bioinformatics enters a new era of artificial intelligence (AI) driven discovery, the composition of our training data has never mattered more. How can we build a future of personalized medicine on a foundation that only represents less than 20% of the worldâ€™s population?\u003C/p>\n\u003Ch3 id=\"the-human-problem-a-legacy-of-distrust\">The Human Problem: A Legacy of Distrust\u003C/h3>\n\u003Cp>To improve our biological models, we must prioritize diverse dataset collection. However, while the solution seems straightforward, the reality is far more complex. The scientific communityâ€™s painful history of human exploitation and data misuse continues to stifle many communitiesâ€™ willingness to participate in research studies.\u003C/p>\n\u003Cp>These scars run deep. From 1932 to 1972, with support from state and local governments, the US Public Health Service conducted what became known as the Tuskegee Syphilis Study, misleading impoverished Black male sharecroppers to participate in a treatment program for their â€œbad bloodâ€ \u003Csup>\u003Ca href=\"#user-content-fn-2\" id=\"user-content-fnref-2\" data-footnote-ref=\"\" aria-describedby=\"footnote-label\">2\u003C/a>\u003C/sup>, \u003Csup>\u003Ca href=\"#user-content-fn-3\" id=\"user-content-fnref-3\" data-footnote-ref=\"\" aria-describedby=\"footnote-label\">3\u003C/a>\u003C/sup>. In reality, the program was a study of the progression of untreated syphilis. Withheld from diagnoses and available treatment, hundreds of participants lost their lives from the disease in the name of scientific advancement.\u003C/p>\n\u003Cp>Even well-intentioned research can have ethical missteps that deepen distrust. In the 1990s, as the rate of diabetes climbed in the Havasupai tribe, an indigenous community near the Grand Canyon, around 650 members donated blood samples to Arizona State University to study genetic links to diabetes \u003Csup>\u003Ca href=\"#user-content-fn-4\" id=\"user-content-fnref-4\" data-footnote-ref=\"\" aria-describedby=\"footnote-label\">4\u003C/a>\u003C/sup>. Approximately a hundred participants signed a consent form allowing their samples to be used to â€œstudy the causes of behavior/medical disorders.â€ However, with English as a second language for many participants and most having never completed high school, the full implications of this broad consent were at high risk of not being understood. Therefore, when researchers used the tribeâ€™s samples in studies unrelated to diabetes, it was done with disregard to the civil rights of the Havasupai tribe to self-determination. Rightfully, the Havasupai tribe sued the university and has refused to participate in any further studies.\u003C/p>\n\u003Cp>More recently, the rise of consumer genetic testing, such as those offered by 23andMe, has made it easy to share genetic data. However, these platforms have also raised concerns about data transparency for marginalized communities \u003Csup>\u003Ca href=\"#user-content-fn-5\" id=\"user-content-fnref-5\" data-footnote-ref=\"\" aria-describedby=\"footnote-label\">5\u003C/a>\u003C/sup>. These companies tell consumers that consumers own their personal data. However, for communities who are already wary of government surveillance and over-policing, the knowledge that their genetic information could potentially be sold to pharmaceutical companies to develop medicine that they will not have access to or accessed by law enforcement in ways that could lead to wrongful convictions for them or a family member adds another layer of hesitation to research participation.\u003C/p>\n\u003Cp>The examples listed only touch the surface of these deeply rooted issues that plague distrust of the scientific community, and I encourage readers to learn more outside the context of this article.\u003C/p>\n\u003Ch3 id=\"a-path-forward-dei-as-a-framework-for-rebuilding-trust\">A Path Forward: DEI as a Framework for Rebuilding Trust\u003C/h3>\n\u003Cp>History shows that trust in science, even after profound breaches, can be rebuilt. The atrocities conducted by medical professionals in the Holocaust ruptured the relationship between science and Jewish communities \u003Csup>\u003Ca href=\"#user-content-fn-6\" id=\"user-content-fnref-6\" data-footnote-ref=\"\" aria-describedby=\"footnote-label\">6\u003C/a>\u003C/sup>. Despite this history, today the Ashkenazi Jewish population is among the most studied groups in human genomics. This reconciliation was made possible through decades of ethical reform and intentional efforts to include and support Jewish scientists.\u003C/p>\n\u003Cp>The Nuremberg Code, a framework established in response to unethical Nazi medical experiments, set up crucial protections for research participants through informed consent and participant autonomy \u003Csup>\u003Ca href=\"#user-content-fn-7\" id=\"user-content-fnref-7\" data-footnote-ref=\"\" aria-describedby=\"footnote-label\">7\u003C/a>\u003C/sup>. However, while these protections support equitable practices, they did not insure participants have meaningful representation and decision-making power in the research itself. For the Jewish community, this gap was filled by inclusive practices like the Rockefeller Foundationâ€™s Refugee Scholar Program, which resettled Jewish scientists and supported their continued involvement in research despite widespread persecution \u003Csup>\u003Ca href=\"#user-content-fn-8\" id=\"user-content-fnref-8\" data-footnote-ref=\"\" aria-describedby=\"footnote-label\">8\u003C/a>\u003C/sup>. This combination of ethical frameworks and institutional inclusion likely contributed significantly to rebuilding trust between Jewish communities and scientific institutions.\u003C/p>\n\u003Cp>Until recently, we were seeing similar patterns emerging through initiatives of inclusion. Researchers from communities affected by HIV/AIDS has been associated with improved rates of community engagement in research and better treatment outcomes \u003Csup>\u003Ca href=\"#user-content-fn-9\" id=\"user-content-fnref-9\" data-footnote-ref=\"\" aria-describedby=\"footnote-label\">9\u003C/a>\u003C/sup>. Similarly, Indigenous health research programs indicate that studies of their communities benefit from Indigenous leadership by increasing community engagement and fostering resources to support non-Indigenous research team members to develop cultural competency \u003Csup>\u003Ca href=\"#user-content-fn-10\" id=\"user-content-fnref-10\" data-footnote-ref=\"\" aria-describedby=\"footnote-label\">10\u003C/a>\u003C/sup>. These studies ensured that voices of the communities they were doing research on were empowered to shape the research process, from study design to data interpretation.\u003C/p>\n\u003Cp>It must be emphasized that practicing DEI is not a quick fix. DEI practices must be sustained, proactive commitments to ensure diversity through informed consent and inclusion. As genomics continues to evolve, so must our standards for how research is conducted, whose data is included, and how the data is used. By building trust, we build better science and, in turn, better health outcomes for everyone.\u003C/p>\n\u003Cp>As we stand at the threshold of AI-driven genomics, we have a choice to make. We can continue building models on a narrow foundation that serves only a fraction of humanity, or we can invest in the trust-building work necessary to create truly inclusive research. The technical quality of our science depends on our decision.\u003C/p>\n\u003Ch3 id=\"references\">References:\u003C/h3>\n\u003Csection data-footnotes=\"\" class=\"footnotes\">\u003Ch2 class=\"sr-only\" id=\"footnote-label\">Footnotes\u003C/h2>\n\u003Col>\n\u003Cli id=\"user-content-fn-1\">\n\u003Cp>Fatumo, S., Chikowore, T., Choudhury, A., Ayub, M., Martin, A. R., &#x26; KuchenbÃ¤cker, K. (2022). Diversity in genomic studies: a roadmap to address the imbalance. Nature medicine, 28(2), 243. \u003Ca href=\"#user-content-fnref-1\" data-footnote-backref=\"\" aria-label=\"Back to reference 1\" class=\"data-footnote-backref\">â†©\u003C/a>\u003C/p>\n\u003C/li>\n\u003Cli id=\"user-content-fn-2\">\n\u003Cp>Jones, J. H. (1993). Bad blood: the Tuskegee syphilis experiment. New and expanded ed. New York. \u003Ca href=\"#user-content-fnref-2\" data-footnote-backref=\"\" aria-label=\"Back to reference 2\" class=\"data-footnote-backref\">â†©\u003C/a>\u003C/p>\n\u003C/li>\n\u003Cli id=\"user-content-fn-3\">\n\u003Cp>Gray, F. (1998). The Tuskegee syphilis study: An insiderâ€™s account. Montgomery, AL: Black Belt. \u003Ca href=\"#user-content-fnref-3\" data-footnote-backref=\"\" aria-label=\"Back to reference 3\" class=\"data-footnote-backref\">â†©\u003C/a>\u003C/p>\n\u003C/li>\n\u003Cli id=\"user-content-fn-4\">\n\u003Cp>Sterling, R. L. (2011). Genetic research among the Havasupai: a cautionary tale. AMA Journal of Ethics, 13(2), 113-117. \u003Ca href=\"#user-content-fnref-4\" data-footnote-backref=\"\" aria-label=\"Back to reference 4\" class=\"data-footnote-backref\">â†©\u003C/a>\u003C/p>\n\u003C/li>\n\u003Cli id=\"user-content-fn-5\">\n\u003Cp>Raz, A. E., Niemiec, E., Howard, H. C., Sterckx, S., Cockbain, J., &#x26; Prainsack, B. (2020). Transparency, consent and trust in the use of customersâ€™ data by an online genetic testing company: an exploratory survey among 23andMe users. New Genetics and Society, 39(4), 459-482. \u003Ca href=\"#user-content-fnref-5\" data-footnote-backref=\"\" aria-label=\"Back to reference 5\" class=\"data-footnote-backref\">â†©\u003C/a>\u003C/p>\n\u003C/li>\n\u003Cli id=\"user-content-fn-6\">\n\u003Cp>Lagnado, L. M., &#x26; Dekel, S. C. (1992). Children of the flames: Dr. Josef Mengele and the untold story of the twins of Auschwitz. Penguin. \u003Ca href=\"#user-content-fnref-6\" data-footnote-backref=\"\" aria-label=\"Back to reference 6\" class=\"data-footnote-backref\">â†©\u003C/a>\u003C/p>\n\u003C/li>\n\u003Cli id=\"user-content-fn-7\">\n\u003Cp>Trials of War Criminals before the Nuremberg Military Tribunals under Control Council Law No. 10. (n.d.). Permissible medical experiments. (Vol. 2, pp. 181-182). Washington, D.C.: U.S. Government Printing Office. \u003Ca href=\"#user-content-fnref-7\" data-footnote-backref=\"\" aria-label=\"Back to reference 7\" class=\"data-footnote-backref\">â†©\u003C/a>\u003C/p>\n\u003C/li>\n\u003Cli id=\"user-content-fn-8\">\n\u003Cp>Iacobelli, T. (2021). The Rockefeller Foundationâ€™s Refugee Scholar Program. \u003Ca href=\"#user-content-fnref-8\" data-footnote-backref=\"\" aria-label=\"Back to reference 8\" class=\"data-footnote-backref\">â†©\u003C/a>\u003C/p>\n\u003C/li>\n\u003Cli id=\"user-content-fn-9\">\n\u003Cp>Karris, M. Y., Dube, K., &#x26; Moore, A. A. (2020). What lessons it might teach us? Community engagement in HIV research. Current Opinion in HIV and AIDS, 15(2), 142-149. \u003Ca href=\"#user-content-fnref-9\" data-footnote-backref=\"\" aria-label=\"Back to reference 9\" class=\"data-footnote-backref\">â†©\u003C/a>\u003C/p>\n\u003C/li>\n\u003Cli id=\"user-content-fn-10\">\n\u003Cp>Woods, C., Settee, C., Beaucage, M., Robinson-Settee, H., Desjarlais, A., Adams, E., â€¦ &#x26; Nahanee, D. (2023). Ensuring Indigenous co-leadership in health research: a Can-SOLVE CKD case example. International Journal for Equity in Health, 22(1), 234. \u003Ca href=\"#user-content-fnref-10\" data-footnote-backref=\"\" aria-label=\"Back to reference 10\" class=\"data-footnote-backref\">â†©\u003C/a>\u003C/p>\n\u003C/li>\n\u003C/ol>\n\u003C/section>",{"headings":37,"localImagePaths":55,"remoteImagePaths":56,"frontmatter":57,"imagePaths":62},[38,42,45,48,51],{"depth":39,"slug":40,"text":41},3,"the-technical-problem-sampling-bias","The Technical Problem: Sampling Bias",{"depth":39,"slug":43,"text":44},"the-human-problem-a-legacy-of-distrust","The Human Problem: A Legacy of Distrust",{"depth":39,"slug":46,"text":47},"a-path-forward-dei-as-a-framework-for-rebuilding-trust","A Path Forward: DEI as a Framework for Rebuilding Trust",{"depth":39,"slug":49,"text":50},"references","References:",{"depth":52,"slug":53,"text":54},2,"footnote-label","Footnotes",[],[],{"title":14,"excerpt":15,"publishDate":58,"tags":59,"seo":60},"Sep 1 2025",[19,20,21,22,23,24,25],{"image":61},{"src":28,"alt":29},[],"20251124",{"id":63,"data":65,"body":73,"filePath":74,"digest":75,"rendered":76},{"title":66,"excerpt":14,"publishDate":67,"isFeatured":17,"tags":68,"seo":69},"The Biobank Iceberg: Understanding Hidden Data Complexities",["Date","2025-09-01T04:00:00.000Z"],[19,20,21,22,23,24,25],{"image":70,"pageType":30},{"src":71,"alt":72},"/biobank_iceberg.png","Iceberg diagram illustrating hidden complexities in biobank data: visible raw data above the waterline, and three categories of hidden challenges below: batch effects, population stratification, and inaccurate phenotype data.","\u003Cfigure>\n\u003Cimg src=\"/biobank_iceberg.png\" alt=\"Iceberg diagram illustrating hidden complexities in biobank data: visible raw data above the waterline, and three categories of hidden challenges below: batch effects, population stratification, and inaccurate phenotype data.\" class=\"block dark:hidden\">\n\u003Cimg src=\"/biobank_iceberg_dark.png\" alt=\"Iceberg diagram illustrating hidden complexities in biobank data: visible raw data above the waterline, and three categories of hidden challenges below: batch effects, population stratification, and inaccurate phenotype data.\" class=\"hidden dark:block\">\n\u003Cfigcaption class=\"text-center text-sm opacity-80 mt-2\">\n    \u003Cstrong>Image 1:\u003C/strong> \u003Cem>The Biobank Iceberg. Everyone knows there's more beneath the surface of Biobank data. The challenge is understanding the scale of these complexities.\u003C/em>\n  \u003C/figcaption>\n\u003C/figure>\n\nIf I learned anything working with the UK Biobank Research Analysis Platform and All of Us Workbench, it's this: don't fear the iceberg. As researchers, we're trained to be skeptical. Every dataset comes with biases and baggage. The temptation is to dive straight inâ€”find the clinical phenotypes, grab the genomic data, and start analyzing. But that approach ignores the complexity lurking beneath the surface.\n\nThe good news: this complexity isn't insurmountable. It just requires understanding the data first. With this post, I hope to demystify UK Biobank and All of Us so you can navigate them confidently, armed with knowledge of what to watch for.\n\n## Phenotype Data\n\nAll of Us recommends starting with their Cohort and Dataset Builders, point-and-click tools designed to help researchers navigate the data. But as a bioinformatician, I was more comfortable diving into the code iteself. I skipped the builders and went straight to querying the [SQL tables](https://support.researchallofus.org/hc/en-us/articles/30125602539284-Introduction-to-All-of-Us-Electronic-Health-Record-EHR-Collection-and-Data-Transformation-Methods) directly. From there, I was greeted with the familiar face of messy phenotype data. Let me introduce you.\n\n\u003Cimg src=\"/source_to_standard_omop.png\" alt=\"Flowchart showing the process of transforming hospital EHR data into OMOP format.\" class=\"block dark:hidden\">\n\u003Cimg src=\"/source_to_standard_omop_dark.png\" alt=\"Flowchart showing the process of transforming hospital EHR data into OMOP format.\" class=\"hidden dark:block\">\n\n**Image 2:** _EHR to OMOP Flowchart. Raw hospital data with inconsistent coding is extracted, transformed into standardized concepts through the OMOP vocabulary, and loaded into relational tables for research use._\n\nData collected by All of Us originates from multiple sources including self-reported surveys, program enrollment visits, and electronic health records. healthcare provider organizations","src/content/blog/20251124.md","fd8fb8a40ab96456",{"html":77,"metadata":78},"\u003Cfigure>\n\u003Cimg src=\"/biobank_iceberg.png\" alt=\"Iceberg diagram illustrating hidden complexities in biobank data: visible raw data above the waterline, and three categories of hidden challenges below: batch effects, population stratification, and inaccurate phenotype data.\" class=\"block dark:hidden\">\n\u003Cimg src=\"/biobank_iceberg_dark.png\" alt=\"Iceberg diagram illustrating hidden complexities in biobank data: visible raw data above the waterline, and three categories of hidden challenges below: batch effects, population stratification, and inaccurate phenotype data.\" class=\"hidden dark:block\">\n\u003Cfigcaption class=\"text-center text-sm opacity-80 mt-2\">\n    \u003Cstrong>Image 1:\u003C/strong> \u003Cem>The Biobank Iceberg. Everyone knows there's more beneath the surface of Biobank data. The challenge is understanding the scale of these complexities.\u003C/em>\n  \u003C/figcaption>\n\u003C/figure>\n\u003Cp>If I learned anything working with the UK Biobank Research Analysis Platform and All of Us Workbench, itâ€™s this: donâ€™t fear the iceberg. As researchers, weâ€™re trained to be skeptical. Every dataset comes with biases and baggage. The temptation is to dive straight inâ€”find the clinical phenotypes, grab the genomic data, and start analyzing. But that approach ignores the complexity lurking beneath the surface.\u003C/p>\n\u003Cp>The good news: this complexity isnâ€™t insurmountable. It just requires understanding the data first. With this post, I hope to demystify UK Biobank and All of Us so you can navigate them confidently, armed with knowledge of what to watch for.\u003C/p>\n\u003Ch2 id=\"phenotype-data\">Phenotype Data\u003C/h2>\n\u003Cp>All of Us recommends starting with their Cohort and Dataset Builders, point-and-click tools designed to help researchers navigate the data. But as a bioinformatician, I was more comfortable diving into the code iteself. I skipped the builders and went straight to querying the \u003Ca href=\"https://support.researchallofus.org/hc/en-us/articles/30125602539284-Introduction-to-All-of-Us-Electronic-Health-Record-EHR-Collection-and-Data-Transformation-Methods\">SQL tables\u003C/a> directly. From there, I was greeted with the familiar face of messy phenotype data. Let me introduce you.\u003C/p>\n\u003Cimg src=\"/source_to_standard_omop.png\" alt=\"Flowchart showing the process of transforming hospital EHR data into OMOP format.\" class=\"block dark:hidden\">\n\u003Cimg src=\"/source_to_standard_omop_dark.png\" alt=\"Flowchart showing the process of transforming hospital EHR data into OMOP format.\" class=\"hidden dark:block\">\n\u003Cp>\u003Cstrong>Image 2:\u003C/strong> \u003Cem>EHR to OMOP Flowchart. Raw hospital data with inconsistent coding is extracted, transformed into standardized concepts through the OMOP vocabulary, and loaded into relational tables for research use.\u003C/em>\u003C/p>\n\u003Cp>Data collected by All of Us originates from multiple sources including self-reported surveys, program enrollment visits, and electronic health records. healthcare provider organizations\u003C/p>",{"headings":79,"localImagePaths":83,"remoteImagePaths":84,"frontmatter":85,"imagePaths":89},[80],{"depth":52,"slug":81,"text":82},"phenotype-data","Phenotype Data",[],[],{"title":66,"excerpt":14,"publishDate":58,"tags":86,"seo":87},[19,20,21,22,23,24,25],{"image":88},{"src":71,"alt":72},[],"projects",["Map",92,93,125,126,202,203,273,274,334,335,394,395,503,504],"project-1",{"id":92,"data":94,"body":107,"filePath":108,"digest":109,"rendered":110},{"title":95,"timeperiod":96,"company":97,"publishDate":98,"isFeatured":99,"references":100},"Independent Contractor","Sep 2025 â€“ Present","Genscience, Remote",["Date","2022-09-30T04:00:00.000Z"],true,[101,104],{"label":102,"url":103},"UK Biobank","https://www.ukbiobank.ac.uk/",{"label":105,"url":106},"All of Us Research Program","https://allofus.nih.gov/","## Summary\n\n- Conduct subject-level genetic analysis to investigate the role of genomic variation in disease risk and progression\n- Apply statistical and bioinformatics methods to large-scale datasets to interpret findings and contribute to hypothesis-driven study design","src/content/projects/project-1.md","51ff19fea2cadbd5",{"html":111,"metadata":112},"\u003Ch2 id=\"summary\">Summary\u003C/h2>\n\u003Cul>\n\u003Cli>Conduct subject-level genetic analysis to investigate the role of genomic variation in disease risk and progression\u003C/li>\n\u003Cli>Apply statistical and bioinformatics methods to large-scale datasets to interpret findings and contribute to hypothesis-driven study design\u003C/li>\n\u003C/ul>",{"headings":113,"localImagePaths":117,"remoteImagePaths":118,"frontmatter":119,"imagePaths":124},[114],{"depth":52,"slug":115,"text":116},"summary","Summary",[],[],{"title":95,"timeperiod":96,"company":97,"publishDate":120,"isFeatured":99,"references":121},"Sep 30 2022",[122,123],{"label":102,"url":103},{"label":105,"url":106},[],"project-2",{"id":125,"data":127,"body":174,"filePath":175,"digest":176,"rendered":177},{"title":128,"timeperiod":129,"company":130,"headerImage":131,"publishDate":136,"isFeatured":99,"publications":137,"presentations":144,"references":166,"seo":171},"Postdoctoral Fellow","Feb 2022 â€“ Feb 2025 (3 years)","Pfizer, Cambridge, MA",{"light":132,"dark":133,"alt":134,"caption":135},"public/modifier_barchart_V6.png","public/modifier_barchart_invert_V6.png","Bar chart illustrating the inherited threshold model of disease. The first bar shows complete penetrance in variant carriers; subsequent bars show decreasing penetrance due to common genetic modifiers.","\u003Cstrong>Inherited threshold model of disease\u003C/strong>. This chart illustrates how common genetic modifiers influence the penetrance of rare monogenic diseases. The left bar shows complete penetrance: all carriers of a rare pathogenic variant (blue) are affected. The other bars represent variable penetrance, as seen in conditions like cardiomyopathies.",["Date","2022-02-28T05:00:00.000Z"],[138],{"title":139,"url":140,"authors":141,"venue":142,"year":143},"Common genetic modifiers influence cardiomyopathy susceptibility among the carriers of rare pathogenic variants","https://www.medrxiv.org/content/10.1101/2024.12.17.24318501v1","Klasfeld, S. J., Knutson, K. A., Miller, M. R., Fauman, E. B., Berghout, J., Moccia, R., & Kim, H. I.","Human Genetics and Genomics Advances",2025,[145,152,158,162],{"title":146,"authors":147,"type":148,"venue":149,"location":150,"date":151},"Coding cis pQTLs from proteogenomic data allow evaluation of the performance of missense variant effect predictions and the utility of their application to rare variant association analyses","Klasfeld, S., Fauman, E.B., Miller, M.R., Moccia, R., & Kim, H.I.","Poster","American Society of Human Genetics","Denver, CO","November 5, 2024",{"title":153,"authors":154,"type":148,"venue":155,"location":156,"date":157},"Common genetic modifiers influence disease risk in carriers of rare pathogenic cardiomyopathy variants","Klasfeld, S., Moccia, R., Knutson, A., Berghout, J., & Kim, H.I.","Pfizer Worldwide Research, Development and Medical Postdoc Symposium","Cambridge, MA","November 1, 2023",{"title":159,"authors":154,"type":160,"venue":155,"location":156,"date":161},"Genetic modifiers illuminate clinical phenotype penetrance in carriers of rare cardiomyopathy-causal variants","PowerPoint slides","November 2, 2023",{"title":163,"authors":164,"type":148,"venue":155,"location":156,"date":165},"Genetic modifiers illuminate frequency and penetrance of clinical and subclinical phenotypes in carriers of rare cardiomyopathy-causal variants","Klasfeld, S., Moccia, R., & Berghout, J.","November 2, 2022",[167,168],{"label":102,"url":103},{"label":169,"url":170},"Polygenic Risk Scores","https://www.genome.gov/Health/Genomics-and-Medicine/Polygenic-risk-scores",{"image":172,"pageType":30},{"src":132,"alt":173},"Project preview","## Summary\n\n- Organized genetic and medical data leveraged from self-reports, electronic health records, and ~500K exomes in the [UK biobank](https://www.ukbiobank.ac.uk/) and generated version-controlled code with [git](https://git-scm.com/) to ensure reproducibility\n\n- Leveraged latest update of [UK biobank](https://www.ukbiobank.ac.uk/) to identify a sufficiently sized cohort of known and novel cardiomyopathy variant carriers to improve upon previous studies without adequate statistical power\n\n- Calculated [PRS](https://www.genome.gov/Health/Genomics-and-Medicine/Polygenic-risk-scores) from relevant GWAS and evaluated logistic, cox, and linear regression to quantify the association of common variants on disease penetrance, onset, and severity among the rare pathogenic variant carriers and use the results to provide\n  genetic insight for decreasing disease outcomes\n\n- Articulated technical genetic study in internal symposiums to showcase my work to multidisciplinary audiences including nonsubject\n  matter experts (eg. biologists, leadership)","src/content/projects/project-2.md","579fbf33fa477c52",{"html":178,"metadata":179},"\u003Ch2 id=\"summary\">Summary\u003C/h2>\n\u003Cul>\n\u003Cli>\n\u003Cp>Organized genetic and medical data leveraged from self-reports, electronic health records, and ~500K exomes in the \u003Ca href=\"https://www.ukbiobank.ac.uk/\">UK biobank\u003C/a> and generated version-controlled code with \u003Ca href=\"https://git-scm.com/\">git\u003C/a> to ensure reproducibility\u003C/p>\n\u003C/li>\n\u003Cli>\n\u003Cp>Leveraged latest update of \u003Ca href=\"https://www.ukbiobank.ac.uk/\">UK biobank\u003C/a> to identify a sufficiently sized cohort of known and novel cardiomyopathy variant carriers to improve upon previous studies without adequate statistical power\u003C/p>\n\u003C/li>\n\u003Cli>\n\u003Cp>Calculated \u003Ca href=\"https://www.genome.gov/Health/Genomics-and-Medicine/Polygenic-risk-scores\">PRS\u003C/a> from relevant GWAS and evaluated logistic, cox, and linear regression to quantify the association of common variants on disease penetrance, onset, and severity among the rare pathogenic variant carriers and use the results to provide\ngenetic insight for decreasing disease outcomes\u003C/p>\n\u003C/li>\n\u003Cli>\n\u003Cp>Articulated technical genetic study in internal symposiums to showcase my work to multidisciplinary audiences including nonsubject\nmatter experts (eg. biologists, leadership)\u003C/p>\n\u003C/li>\n\u003C/ul>",{"headings":180,"localImagePaths":182,"remoteImagePaths":183,"frontmatter":184,"imagePaths":201},[181],{"depth":52,"slug":115,"text":116},[],[],{"title":128,"timeperiod":129,"company":130,"headerImage":185,"publishDate":186,"isFeatured":99,"publications":187,"presentations":189,"references":194,"seo":197},{"light":132,"dark":133,"alt":134,"caption":135},"Feb 28 2022",[188],{"title":139,"authors":141,"venue":142,"year":143,"url":140},[190,191,192,193],{"title":146,"authors":147,"type":148,"venue":149,"location":150,"date":151},{"title":153,"authors":154,"type":148,"venue":155,"location":156,"date":157},{"title":159,"authors":154,"type":160,"venue":155,"location":156,"date":161},{"title":163,"authors":164,"type":148,"venue":155,"location":156,"date":165},[195,196],{"label":102,"url":103},{"label":169,"url":170},{"image":198},{"src":132,"alt":173,"width":199,"height":200},200,150,[],"project-5",{"id":202,"data":204,"body":247,"filePath":248,"digest":249,"rendered":250},{"title":205,"timeperiod":206,"company":207,"headerImage":208,"publishDate":212,"isFeatured":17,"relevantPublications":213,"references":226,"seo":245},"Summer Undergraduate Researcher","June 2013 â€“ August 2013 (3 months)","J. Craig Venter Institute, Rockville, MD",{"light":209,"dark":209,"alt":210,"caption":211},"/project-4.png","Screenshot of miRDeep2 output showing a predicted microRNA in Rotylenchulus reniformis, validated by CentroidFold secondary structure analysis.","Predicted microRNA in \u003Ci>Rotylenchulus reniformis\u003C/i>. miRDeep2 output for a candidate microRNA in this plant-parasitic nematode, validated by secondary structure prediction using CentroidFold.",["Date","2013-06-20T04:00:00.000Z"],[214,220],{"title":215,"url":216,"authors":217,"venue":218,"year":219},"Identification of microRNAs and their targets in four Gossypium species using RNA sequencing","https://doi.org/10.1016/j.cpb.2018.09.008","Sripathi, V. R., Choi, Y., Gossett, Z. B., Stelly, D. M., Moss, E. M., Town, C. D., ... & Chan, A. P.","Current Plant Biology",2018,{"title":221,"url":222,"authors":223,"venue":224,"year":225},"An improved genome release (version Mt4.0) for the model legume Medicago truncatula","https://link.springer.com/article/10.1186/1471-2164-15-312","Tang, H., Krishnakumar, V., Bidwell, S., Rosen, B., Chan, A., Zhou, S., ... & Town, C. D.","BMC Genomics",2014,[227,230,233,236,239,242],{"label":228,"url":229},"J. Craig Venter Institute","https://www.jcvi.org/",{"label":231,"url":232},"mirDeep2","https://www.mdc-berlin.de/content/mirdeep2-documentation",{"label":234,"url":235},"CentroidFold","http://rtools.cbrc.jp/centroidfold/",{"label":237,"url":238},"AHA","https://rhallpb.github.io/Applications/AHA.html",{"label":240,"url":241},"PBJelly","https://sourceforge.net/p/pb-jelly/wiki/Home/",{"label":243,"url":244},"Medicago truncatula genome","https://www.jcvi.org/research/medicago-truncatula-genome-database",{"image":246,"pageType":30},{"src":209},"## Summary\n\n- Investigated novel microRNAs in _R. reniformis_\n\n- Assessed [AHA](https://rhallpb.github.io/Applications/AHA.html) and [PBJelly](https://sourceforge.net/p/pb-jelly/wiki/Home/) as gap closing and scaffold tools for _Medicago truncatula_, a legume of scientific interest due to its symbiotic relationships with nitrogen-fixing bacteria and fungi, using PacBio sequencing data","src/content/projects/project-5.md","538997faedd5deda",{"html":251,"metadata":252},"\u003Ch2 id=\"summary\">Summary\u003C/h2>\n\u003Cul>\n\u003Cli>\n\u003Cp>Investigated novel microRNAs in \u003Cem>R. reniformis\u003C/em>\u003C/p>\n\u003C/li>\n\u003Cli>\n\u003Cp>Assessed \u003Ca href=\"https://rhallpb.github.io/Applications/AHA.html\">AHA\u003C/a> and \u003Ca href=\"https://sourceforge.net/p/pb-jelly/wiki/Home/\">PBJelly\u003C/a> as gap closing and scaffold tools for \u003Cem>Medicago truncatula\u003C/em>, a legume of scientific interest due to its symbiotic relationships with nitrogen-fixing bacteria and fungi, using PacBio sequencing data\u003C/p>\n\u003C/li>\n\u003C/ul>",{"headings":253,"localImagePaths":255,"remoteImagePaths":256,"frontmatter":257,"imagePaths":272},[254],{"depth":52,"slug":115,"text":116},[],[],{"title":205,"timeperiod":206,"company":207,"publishDate":258,"headerImage":259,"relevantPublications":260,"references":263,"seo":270},"Jun 20 2013",{"light":209,"dark":209,"alt":210,"caption":211},[261,262],{"title":215,"authors":217,"venue":218,"year":219,"url":216},{"title":221,"authors":223,"venue":224,"year":225,"url":222},[264,265,266,267,268,269],{"label":228,"url":229},{"label":231,"url":232},{"label":234,"url":235},{"label":237,"url":238},{"label":240,"url":241},{"label":243,"url":244},{"image":271},{"src":209},[],"project-6",{"id":273,"data":275,"body":310,"filePath":311,"digest":312,"rendered":313},{"title":205,"timeperiod":276,"company":277,"headerImage":278,"publishDate":284,"isFeatured":17,"relevantPublications":285,"references":292,"seo":308},"June 2012 â€“ August 2012 (3 months)","Boyce Thompson Institute, Ithaca, NY",{"light":279,"dark":280,"alt":281,"caption":282,"longDescription":283},"public/project-5.png","public/project-5_invert.png","Diagram showing two-part pipeline for sweet potato virus genome analysis: alignment of known viruses (left) and assembly of novel viral genomes (right).","\u003Cstrong>Pipeline for sweet potato virus genome analysis\u003C/strong>. The left panel shows alignment of known viral genomes; the right panel illustrates assembly of novel viruses from sequencing data.","\u003Ch3>Sweet Potato Virus Genome Analysis Pipeline\u003C/h3>\u003Ch4>Step 1: Preprocessing\u003C/h4>\u003Cp>Clean raw sequencing data by removing barcodes and adapters.\u003C/p>\u003Ch4>Step 2: Choose Analysis Path\u003C/h4>\u003Ch5>ðŸ§­ Alignment Path\u003C/h5>\u003Col>\u003Cli>Align reads to the virus genome database.\u003C/li>\u003Cli>Correct contigs.\u003C/li>\u003Cli>Remove redundant sequences.\u003C/li>\u003C/ol>\u003Ch5>ðŸ§¬ Assembly Path\u003C/h5>\u003Col>\u003Cli>Assemble contigs using Velvet.\u003C/li>\u003Cli>BLAST against non-redundant protein sequences.\u003C/li>\u003Cli>Compare results back to virus genome contigs.\u003C/li>\u003C/ol>",["Date","2012-06-25T04:00:00.000Z"],[286],{"title":287,"url":288,"authors":289,"venue":290,"year":291},"Determining the pan-African sweetpotato virome: Understanding virus diversity, distribution and evolution and their impacts on sweetpotato production in Africa","https://cgspace.cgiar.org/server/api/core/bitstreams/4947f05c-9ebe-4d8e-9ca8-d17b3e13708d/content","Gutierrez, D., Tachin, M., Schulz, S., Miano, D., Ndunguru, J., Mukassa, S., ... & Kreuze, J. F.","CIP Research Report",2012,[293,296,299,302,305],{"label":294,"url":295},"Boyce Thompson Institute","https://btiscience.org/",{"label":297,"url":298},"Sweet Potato Virome","http://bioinfo.bti.cornell.edu/virome",{"label":300,"url":301},"Velvet Assembler","https://pmc.ncbi.nlm.nih.gov/articles/PMC2336801/",{"label":303,"url":304},"NCBI BLAST","https://blast.ncbi.nlm.nih.gov/Blast.cgi",{"label":306,"url":307},"Fei Lab","http://bioinfo.bti.cornell.edu/",{"image":309,"pageType":30},{"src":279},"## Summary\n\n- [Improved methods to classify known and novel virus siRNA sequences from sweet potato samples more effectively](http://bioinfo.bti.cornell.edu/virome)","src/content/projects/project-6.md","8ad9c1894416103f",{"html":314,"metadata":315},"\u003Ch2 id=\"summary\">Summary\u003C/h2>\n\u003Cul>\n\u003Cli>\u003Ca href=\"http://bioinfo.bti.cornell.edu/virome\">Improved methods to classify known and novel virus siRNA sequences from sweet potato samples more effectively\u003C/a>\u003C/li>\n\u003C/ul>",{"headings":316,"localImagePaths":318,"remoteImagePaths":319,"frontmatter":320,"imagePaths":333},[317],{"depth":52,"slug":115,"text":116},[],[],{"title":205,"timeperiod":276,"company":277,"publishDate":321,"headerImage":322,"relevantPublications":323,"references":325,"seo":331},"Jun 25 2012",{"light":279,"dark":280,"alt":281,"caption":282,"longDescription":283},[324],{"title":287,"authors":289,"venue":290,"year":291,"url":288},[326,327,328,329,330],{"label":294,"url":295},{"label":297,"url":298},{"label":300,"url":301},{"label":303,"url":304},{"label":306,"url":307},{"image":332},{"src":279},[],"project-7",{"id":334,"data":336,"body":370,"filePath":371,"digest":372,"rendered":373},{"title":337,"timeperiod":276,"company":338,"headerImage":339,"publishDate":343,"isFeatured":17,"relevantPublications":344,"references":355,"seo":367},"Undergraduate Researcher","Cornell University, Ithaca, NY",{"light":340,"dark":340,"alt":341,"caption":342},"public/project-6.png","Scatter plots showing fluorescence-based genotyping of pepper resistance alleles using KASP markers. Left: pvr1 genotypes in CC population. Right: Bs3 genotypes in commercial cultivars. Color clusters indicate homozygous wild-type, homozygous resistance, and heterozygotes. Black xâ€™s mark water controls and failed samples.","Genotyping of disease resistance alleles in pepper using KASP markers. Figure adapted from Holdsworth & Mazourek (2015), showing fluorescence-based genotyping of \u003Ci>pvr1\u003C/i> and \u003Ci>Bs3\u003C/i> alleles in \u003Ci>Capsicum annuum\u003C/i>. I contributed to this work as an undergraduate and was acknowledged in the publication.",["Date","2010-05-20T04:00:00.000Z"],[345,350],{"title":346,"url":347,"authors":348,"venue":349,"year":291},"Development and application of a suite of non-pungency markers for the Pun1 gene in pepper (Capsicum spp.)","https://link.springer.com/article/10.1007/s11032-012-9716-9","Wyatt, L. E., Eannetta, N. T., Stellari, G. M., & Mazourek, M.","Molecular Breeding",{"title":351,"url":352,"authors":353,"venue":349,"year":354},"Development of user-friendly markers for the pvr1 and Bs3 disease resistance genes in pepper","https://link.springer.com/article/10.1007/s11032-015-0260-2","Holdsworth, W. L., & Mazourek, M.",2015,[356,359,362,364],{"label":357,"url":358},"Mazourek Lab","https://cals.cornell.edu/people/michael-mazourek",{"label":360,"url":361},"KASP genotyping","https://pubmed.ncbi.nlm.nih.gov/24816661/",{"label":363,"url":304},"BLAST",{"label":365,"url":366},"Polymerase Chain Reaction (PCR)","https://www.genome.gov/genetics-glossary/Polymerase-Chain-Reaction-PCR",{"image":368,"pageType":30},{"src":369},"project-6.png","## Summary\n\n- Compared Genotype by Sequencing data from different restriction enzymes to _Cucurbita pepo_ transcript sequences using [BLAST](https://blast.ncbi.nlm.nih.gov/Blast.cgi)\n\n- Developed and tested [KASP markers](https://www.protocols.io/view/kasp-genotyping-kqdg39qr7g25/v1) for relevant genes in peppers to make available for breeding work\n\n- Extracted DNA and utilized PCR and DNA sequencing to determine whether a mutation in a predicted gene was responsible for the observed phenotype in peppers.","src/content/projects/project-7.md","e1f01bdd1a48f3a5",{"html":374,"metadata":375},"\u003Ch2 id=\"summary\">Summary\u003C/h2>\n\u003Cul>\n\u003Cli>\n\u003Cp>Compared Genotype by Sequencing data from different restriction enzymes to \u003Cem>Cucurbita pepo\u003C/em> transcript sequences using \u003Ca href=\"https://blast.ncbi.nlm.nih.gov/Blast.cgi\">BLAST\u003C/a>\u003C/p>\n\u003C/li>\n\u003Cli>\n\u003Cp>Developed and tested \u003Ca href=\"https://www.protocols.io/view/kasp-genotyping-kqdg39qr7g25/v1\">KASP markers\u003C/a> for relevant genes in peppers to make available for breeding work\u003C/p>\n\u003C/li>\n\u003Cli>\n\u003Cp>Extracted DNA and utilized PCR and DNA sequencing to determine whether a mutation in a predicted gene was responsible for the observed phenotype in peppers.\u003C/p>\n\u003C/li>\n\u003C/ul>",{"headings":376,"localImagePaths":378,"remoteImagePaths":379,"frontmatter":380,"imagePaths":393},[377],{"depth":52,"slug":115,"text":116},[],[],{"title":337,"timeperiod":276,"company":338,"publishDate":381,"headerImage":382,"relevantPublications":383,"references":386,"seo":391},"May 20 2010",{"light":340,"dark":340,"alt":341,"caption":342},[384,385],{"title":346,"authors":348,"venue":349,"year":291,"url":347},{"title":351,"authors":353,"venue":349,"year":354,"url":352},[387,388,389,390],{"label":357,"url":358},{"label":360,"url":361},{"label":363,"url":304},{"label":365,"url":366},{"image":392},{"src":369},[],"project-3",{"id":394,"data":396,"body":468,"filePath":469,"digest":470,"rendered":471},{"title":397,"timeperiod":398,"company":399,"headerImage":400,"publishDate":404,"isFeatured":99,"publications":405,"presentations":434,"references":450,"seo":466},"Graduate Student Researcher","Aug 2015 â€“ Feb 2022 (6 years)","University of Pennsylvania, Philadelphia, PA",{"light":401,"dark":401,"alt":402,"caption":403},"/project-2.png","IGV browser screenshot showing greenscreen and blacklist tracks above bedgraph signals for IgG, H3, and H3K27me3 in Arabidopsis. Greenscreen and blacklist regions align with ultrahigh peaks from mapped reads, indicating shared artifacts across experiments.","From my graduate work on artifact detection in ChIP-seq and Cut & Run datasets, this IGV screenshot shows greenscreen and blacklist tracks (top), and bedgraph signals for IgG, H3, and H3K27me3 (bottom) from fixed and non-fixed Arabidopsis tissues (Zheng & Gehring, 2019). Ultrahigh peaks from mapped reads overlap with greenscreen regions, revealing shared artifacts across experiments(Klasfeld \u003Ci>et al\u003C/i> 2022).",["Date","2015-08-25T04:00:00.000Z"],[406,412,418,423,428],{"title":407,"url":408,"authors":409,"venue":410,"year":411},"Greenscreen: A simple method to remove artifactual signals and enrich for true peaks in genomic datasets including ChIP-seq data","https://academic.oup.com/plcell/article/34/12/4795/6705244","Klasfeld, S., RoulÃ©, T., & Wagner, D.","The Plant Cell",2022,{"title":413,"url":414,"authors":415,"venue":416,"year":417},"Molecular regulation of plant developmental transitions and plant architecture via PEPB family proteinsâ€“an update on mechanism of action","https://doi.org/10.1093/jxb/eraa598","Zhu, Y., Klasfeld, S., & Wagner, D.","Journal of Experimental Botany",2021,{"title":419,"url":420,"authors":421,"venue":422,"year":417},"LEAFY is a pioneer transcription factor and licenses cell reprogramming to floral fate","https://www.nature.com/articles/s41467-020-20883-w","Jin, R., Klasfeld, S., et al., & Wagner, D.","Nature Communications",{"title":424,"url":425,"authors":426,"venue":422,"year":427},"TERMINAL FLOWER 1-FD complex target genes and competition with FLOWERING LOCUS T","https://www.nature.com/articles/s41467-020-18782-1","Zhu, Y., Klasfeld, S., et al., & Wagner, D.",2020,{"title":429,"url":430,"authors":431,"venue":432,"year":433},"Cis and trans determinants of epigenetic silencing by Polycomb repressive complex 2 in Arabidopsis","https://www.nature.com/articles/ng.3937","Xiao, J., .., Klasfeld, S., ..., & Wagner, D.","Nature Genetics",2017,[435,441,446],{"title":436,"authors":437,"type":148,"venue":438,"location":439,"date":440},"Improving resolution of protein binding sites by filtering conserved ultra-high signal in Arabidopsis","Klasfeld, S., & Wagner, D.","University of Pennsylvania Genomics and Computational Biology Graduate Group Retreat","The College of Physicians of Philadelphia, Philadelphia, PA","June 12, 2019",{"title":442,"authors":437,"type":148,"venue":443,"location":444,"date":445},"Resolving the mechanism of PRC2 during plant stress","University of Pennsylvania Epigenetics Retreat","Independence Seaport Museum, Philadelphia, PA","November 15, 2018",{"title":447,"authors":437,"type":148,"venue":443,"location":448,"date":449},"The characterization and discovery of novel Polycomb and Trithorax Recruitment Elements in plants","Citizens Bank Park, Philadelphia, PA","October 13, 2017",[451,454,457,460,463],{"label":452,"url":453},"Wagner Lab","https://web.sas.upenn.edu/wagner-lab/",{"label":455,"url":456},"Greenscreen","https://github.com/sklasfeld/GreenscreenProject",{"label":458,"url":459},"Graduate Research Fellowship Program (GRFP)","https://www.nsf.gov/funding/opportunities/grfp-nsf-graduate-research-fellowship-program/nsf16-588/solicitation",{"label":461,"url":462},"Integrative Genomics Viewer (IGV)","https://igv.org/",{"label":464,"url":465},"Comparative Genomics Platform (CoGe)","https://genomevolution.org/coge/",{"image":467,"pageType":30},{"src":401,"alt":173},"## Summary\n\n- Developed [Greenscreen method](https://github.com/sklasfeld/GreenscreenProject) to accurately identify and mask false-positive ChIP-seq peaks with efficacy in _Arabidopsis_, _Drosophila_, and _Oryza sativa_ resulting in 1st author publication\n\n- Designed and orchestrated Next Generation Sequencing (NGS) data analysis (eg. ChIP-Seq, RNA-seq, MNase-seq) to measure the activity and outcomes of mobile and DNA binding proteins functional in cellular reprogramming, resulting in three 2nd author publications\n\n## Selected Awards\n\n- Honorable Mention of the 2016 National Science Foundation (NSF) Graduate Research Fellowship","src/content/projects/project-3.md","d134befad879593a",{"html":472,"metadata":473},"\u003Ch2 id=\"summary\">Summary\u003C/h2>\n\u003Cul>\n\u003Cli>\n\u003Cp>Developed \u003Ca href=\"https://github.com/sklasfeld/GreenscreenProject\">Greenscreen method\u003C/a> to accurately identify and mask false-positive ChIP-seq peaks with efficacy in \u003Cem>Arabidopsis\u003C/em>, \u003Cem>Drosophila\u003C/em>, and \u003Cem>Oryza sativa\u003C/em> resulting in 1st author publication\u003C/p>\n\u003C/li>\n\u003Cli>\n\u003Cp>Designed and orchestrated Next Generation Sequencing (NGS) data analysis (eg. ChIP-Seq, RNA-seq, MNase-seq) to measure the activity and outcomes of mobile and DNA binding proteins functional in cellular reprogramming, resulting in three 2nd author publications\u003C/p>\n\u003C/li>\n\u003C/ul>\n\u003Ch2 id=\"selected-awards\">Selected Awards\u003C/h2>\n\u003Cul>\n\u003Cli>Honorable Mention of the 2016 National Science Foundation (NSF) Graduate Research Fellowship\u003C/li>\n\u003C/ul>",{"headings":474,"localImagePaths":479,"remoteImagePaths":480,"frontmatter":481,"imagePaths":502},[475,476],{"depth":52,"slug":115,"text":116},{"depth":52,"slug":477,"text":478},"selected-awards","Selected Awards",[],[],{"title":397,"timeperiod":398,"company":399,"publishDate":482,"isFeatured":99,"headerImage":483,"publications":484,"presentations":490,"seo":494,"references":496},"Aug 25 2015",{"light":401,"dark":401,"alt":402,"caption":403},[485,486,487,488,489],{"title":407,"authors":409,"venue":410,"year":411,"url":408},{"title":413,"authors":415,"venue":416,"year":417,"url":414},{"title":419,"authors":421,"venue":422,"year":417,"url":420},{"title":424,"authors":426,"venue":422,"year":427,"url":425},{"title":429,"authors":431,"venue":432,"year":433,"url":430},[491,492,493],{"title":436,"authors":437,"type":148,"venue":438,"location":439,"date":440},{"title":442,"authors":437,"type":148,"venue":443,"location":444,"date":445},{"title":447,"authors":437,"type":148,"venue":443,"location":448,"date":449},{"image":495},{"src":401,"alt":173},[497,498,499,500,501],{"label":452,"url":453},{"label":455,"url":456},{"label":458,"url":459},{"label":461,"url":462},{"label":464,"url":465},[],"project-4",{"id":503,"data":505,"body":551,"filePath":552,"digest":553,"rendered":554},{"title":506,"timeperiod":507,"company":508,"headerImage":509,"publishDate":513,"isFeatured":99,"publications":514,"presentations":521,"references":527,"seo":549},"Postbaccalaureate Fellow","Aug 2014 â€“ June 2015 (1 year)","National Institutes of Health, Bethesda, MD",{"light":510,"dark":510,"alt":511,"caption":512},"/project-3.png","Screenshot of miRDeep2 output showing a predicted microRNA in Hydractinia that passed filtering based on secondary structure, miRDeep2 score, and strand homogeneity.","High-confidence microRNA candidate in Hydractinia. This screenshot shows miRDeep2 output for a predicted microRNA that passed automated filtering based on secondary structure and computational scoring. (\u003Ca href=\"https://genome.cshlp.org/content/suppl/2024/04/15/gr.278382.123.DC1/Supplemental_Material.pdf\">Schnitzler \u003Ci>et al\u003C/i> 2022\u003C/a>).",["Date","2014-08-01T04:00:00.000Z"],[515],{"title":516,"url":517,"authors":518,"venue":519,"year":520},"The genome of the colonial hydroid Hydractinia reveals that their stem cells use a toolkit of evolutionarily shared genes with all animals","https://genome.cshlp.org/content/34/3/498.short","Schnitzler, C., ..., Klasfeld, S.,  ..., & Baxevanis, A.","Genome Res.",2024,[522],{"title":523,"authors":524,"type":160,"venue":525,"date":526},"Small RNA discovery and expression during regeneration in the colonial hydroid, Hydractinia","Klasfeld, S., Baxevanis, A., & Schnitzler, C.","Bioinformatics Scientific Interest Group (BSIG), NIH","October 22, 2015",[528,531,534,537,539,542,545,548],{"label":529,"url":530},"The Hydractinia genome project portal","https://research.nhgri.nih.gov/hydractinia/",{"label":532,"url":533},"NIH Bioinformatics Scientific Interest Group","https://oir.nih.gov/sigs/bioinformatics-scientific-interest-group",{"label":535,"url":536},"NIH Postbaccalaureate Poster Day","https://www.training.nih.gov/me/ppd/",{"label":538,"url":530},"Hydractinia Genome Project Portal",{"label":540,"url":541},"Baxevanis Lab","https://www.genome.gov/staff/Andy-Baxevanis-PhD",{"label":543,"url":544},"Schnitzler Lab","https://www.whitney.ufl.edu/people/current-research-faculty/christine-e-schnitzler-phd/",{"label":546,"url":547},"miRBase","https://www.mirbase.org/",{"label":231,"url":232},{"image":550,"pageType":30},{"src":510},"## Summary\n\n- Collaborated with computational biologists to analyze the genomes of Hydractinia echinata and Hydractinia symbiolongicarpus by designing and implementing analysis of novel small RNAs during head regeneration for publication\n- Employed a domain architecture search strategy to identify TRAF immune genes in the genomes of multiple eukaryotes to explore _Cnidarian_ evolution\n\n## Presentations\n\n- Klasfeld, S., Baxevanis, A., & Schnitzler, C. (2015, October 22). Small RNA discovery and expression during regeneration in the\n  colonial hydroid, Hydractinia [PowerPoint slides]. Bioinformatics Scientific Interest Group (BSIG), NIH.\n\n## Selected Awards\n\n- Outstanding Poster Award at NIH Post Baccalaureate Poster Day 2015\n\n- Bioinformatics-Scientific Interest Group 3rd Annual Poster Day Winner (First Place)","src/content/projects/project-4.md","ae1f6023377266d5",{"html":555,"metadata":556},"\u003Ch2 id=\"summary\">Summary\u003C/h2>\n\u003Cul>\n\u003Cli>Collaborated with computational biologists to analyze the genomes of Hydractinia echinata and Hydractinia symbiolongicarpus by designing and implementing analysis of novel small RNAs during head regeneration for publication\u003C/li>\n\u003Cli>Employed a domain architecture search strategy to identify TRAF immune genes in the genomes of multiple eukaryotes to explore \u003Cem>Cnidarian\u003C/em> evolution\u003C/li>\n\u003C/ul>\n\u003Ch2 id=\"presentations\">Presentations\u003C/h2>\n\u003Cul>\n\u003Cli>Klasfeld, S., Baxevanis, A., &#x26; Schnitzler, C. (2015, October 22). Small RNA discovery and expression during regeneration in the\ncolonial hydroid, Hydractinia [PowerPoint slides]. Bioinformatics Scientific Interest Group (BSIG), NIH.\u003C/li>\n\u003C/ul>\n\u003Ch2 id=\"selected-awards\">Selected Awards\u003C/h2>\n\u003Cul>\n\u003Cli>\n\u003Cp>Outstanding Poster Award at NIH Post Baccalaureate Poster Day 2015\u003C/p>\n\u003C/li>\n\u003Cli>\n\u003Cp>Bioinformatics-Scientific Interest Group 3rd Annual Poster Day Winner (First Place)\u003C/p>\n\u003C/li>\n\u003C/ul>",{"headings":557,"localImagePaths":563,"remoteImagePaths":564,"frontmatter":565,"imagePaths":583},[558,559,562],{"depth":52,"slug":115,"text":116},{"depth":52,"slug":560,"text":561},"presentations","Presentations",{"depth":52,"slug":477,"text":478},[],[],{"title":506,"timeperiod":507,"company":508,"publishDate":566,"isFeatured":99,"headerImage":567,"publications":568,"presentations":570,"references":572,"seo":581},"Aug 01 2014",{"light":510,"dark":510,"alt":511,"caption":512},[569],{"title":516,"authors":518,"venue":519,"year":520,"url":517},[571],{"title":523,"authors":524,"type":160,"venue":525,"date":526},[573,574,575,576,577,578,579,580],{"label":529,"url":530},{"label":532,"url":533},{"label":535,"url":536},{"label":538,"url":530},{"label":540,"url":541},{"label":543,"url":544},{"label":546,"url":547},{"label":231,"url":232},{"image":582},{"src":510},[],"pages",["Map",586,587,603,604],"terms",{"id":586,"data":588,"body":592,"filePath":593,"digest":594,"rendered":595},{"title":589,"seo":590},"Terms of Service",{"title":589,"description":591,"pageType":30},"Explore the terms and conditions of Dante website for a clear understanding of guidelines and responsibilities.","\u003C!---\n**Last updated on January 11, 2024**\n\nThese Terms of Service (\"Terms\") govern your access to and use of [Website Name] (\"the Website\") and any related services provided by [Website Owner/Company] (\"we,\" \"us,\" or \"our\"). Please read these Terms carefully before using the Website.\n\n**1. Acceptance of Terms**\n\nBy accessing or using the Website, you agree to be bound by these Terms and our Privacy Policy. If you do not agree to these Terms or the Privacy Policy, please do not use the Website.\n\n**2. Changes to Terms**\n\nWe reserve the right to modify, amend, or update these Terms at any time. Such changes will be effective upon posting on the Website. It is your responsibility to review these Terms regularly. Your continued use of the Website after any changes indicates your acceptance of the revised Terms.\n\n**3. Use of the Website**\n\nYou agree to use the Website for lawful purposes and in a manner consistent with these Terms. You are responsible for any content you post or submit on the Website.\n\n**4. Registration and Account**\n\nCertain areas of the Website may require registration or the creation of an account. You agree to provide accurate, current, and complete information during the registration process and to update such information to keep it accurate, current, and complete. You are responsible for maintaining the confidentiality of your account credentials and for all activities that occur under your account.\n\n**5. Content and Intellectual Property**\n\nThe content on the Website, including text, graphics, logos, images, audio, video, software, and other materials, is owned or licensed by us and is protected by copyright and other intellectual property laws. You may not use, reproduce, or distribute the content without our prior written consent.\n\n**6. Third-Party Links**\n\nThe Website may contain links to third-party websites or resources. We do not endorse and are not responsible for the content, products, or services provided by third parties. Your use of such websites is at your own risk.\n\n**7. Termination**\n\nWe may, at our sole discretion, terminate or suspend your access to the Website at any time and for any reason, without notice.\n\n**8. Disclaimer**\n\nThe Website and its content are provided on an \"as is\" and \"as available\" basis. We make no warranties or representations about the accuracy or completeness of the content. We do not guarantee that the Website will be error-free or uninterrupted.\n\n**9. Limitation of Liability**\n\nTo the fullest extent permitted by law, we shall not be liable for any direct, indirect, incidental, special, consequential, or exemplary damages, including but not limited to damages for loss of profits, goodwill, use, data, or other intangible losses, arising out of or in connection with the use or inability to use the Website.\n\n**10. Governing Law**\n\nThese Terms are governed by and construed in accordance with the laws of [Your Jurisdiction], without regard to its conflict of laws principles. Any disputes arising under these Terms shall be subject to the exclusive jurisdiction of the courts of [Your Jurisdiction].\n\n_Thank you for reading our Terms of Service. By using the Website, you agree to be bound by these Terms._\n\n-->","src/content/pages/terms.md","f56d5a030752b689",{"html":592,"metadata":596},{"headings":597,"localImagePaths":598,"remoteImagePaths":599,"frontmatter":600,"imagePaths":602},[],[],[],{"title":589,"seo":601},{"title":589,"description":591},[],"about",{"id":603,"data":605,"body":613,"filePath":614,"digest":615,"rendered":616},{"title":606,"seo":607},"About",{"title":608,"description":609,"image":610,"pageType":30},"About Me","Learn more about the person behind the website and embark on a journey of inspiration and shared experiences.",{"src":611,"alt":612},"/professional_photo_sklasfeld.jpeg","Samantha Klasfeld","![Alt text for image](/professional_photo_sklasfeld.jpeg)\n\n**Note!:** This about page is a work in progress.\n\n## Samantha Klasfeld - Computational Biologist currently based in Cambridge, MA\n\n**Greetings!** I'm Samantha Klasfeld, I am working on building this website to showcase my career as I pursue my next professional opportunity.\n\n## Education\n* University of Pennsylvania | Perelman School of Medicine | Philadelphia, PA\nDoctor of Philosophy in Genomics and Computational Biology, 2015-2021\n\n* Cornell University | College of Agriculture and Life Sciences | Ithaca, NY\nBachelor of Science in Biology, Concentration in Computational Biology, 2010-2014\n\n## Skills and Expertise\n\n* Workflow development: published ChIP-seq methods, experience with Github, Docker, conda, Nextflow, Snakemake\n* Programming languages: Unix/Linux, Python, R programming, command line, git, SQL, Apache spark, Matlab, Perl, and Java\n* Genomics software: BWA, Bowtie, Bowtie2, STAR, kallisto, MACS2, UMAP, Blacklist, DiffBind, DESeq2, EdgeR, sleuth,\nDANPOS2, DANPOS3, FASTQC, bedtools, samtools, deeptools, MEME, HOMER, AHA, PBJelly, miRDeep2, miRDeep*, miREAP,\nmiRdentify, Centroidfold, CAP-miRSeq\n* Databases: UK Biobank, gnomAD, GTex, ClinVar, dbNSFP, Clingen, Genebass, dbSNP\n* Genetics software: PLINK, VCFtools, bcftools, VEP, LOFTEE, MutPred2, ESM1b, AlphaMissense\n\n\u003C!---\n\n## Innovation and Problem-Solving\n\nI thrive on solving complex problems and transforming ideas into functional, elegant websites. Whether it's optimizing performance, implementing new features, or troubleshooting issues, I approach each challenge with enthusiasm and a commitment to delivering high-quality solutions.\n\n## Global Perspective, Local Impact\n\nLiving in Estonia has not only influenced my appreciation for nature and culture but has also shaped my approach to web development. I understand the importance of creating digital solutions that resonate with local audiences while maintaining a global perspective.\n\n## Continuous Learning\n\nThe dynamic nature of the tech industry inspires me to stay up-to-date with the latest trends and advancements. I'm always eager to expand my skill set and embrace emerging technologies that enhance the functionality and aesthetics of the websites I create.\n\n## Collaboration and Communication\n\nI believe in the power of collaboration and effective communication. Whether working with clients, designers, or fellow developers, I value clear communication to ensure the success of every project.\n\n## Get in Touch\n\nAre you looking to elevate your online presence or bring your digital ideas to life? I'd love to hear from you! Feel free to reach out for collaboration, consultation, or just a friendly chat about all things web development.\n\n_Let's build something amazing together!_\n\n-->","src/content/pages/about.md","f44326bc8feda728",{"html":617,"metadata":618},"\u003Cp>\u003Cimg src=\"/professional_photo_sklasfeld.jpeg\" alt=\"Alt text for image\">\u003C/p>\n\u003Cp>\u003Cstrong>Note!:\u003C/strong> This about page is a work in progress.\u003C/p>\n\u003Ch2 id=\"samantha-klasfeld---computational-biologist-currently-based-in-cambridge-ma\">Samantha Klasfeld - Computational Biologist currently based in Cambridge, MA\u003C/h2>\n\u003Cp>\u003Cstrong>Greetings!\u003C/strong> Iâ€™m Samantha Klasfeld, I am working on building this website to showcase my career as I pursue my next professional opportunity.\u003C/p>\n\u003Ch2 id=\"education\">Education\u003C/h2>\n\u003Cul>\n\u003Cli>\n\u003Cp>University of Pennsylvania | Perelman School of Medicine | Philadelphia, PA\nDoctor of Philosophy in Genomics and Computational Biology, 2015-2021\u003C/p>\n\u003C/li>\n\u003Cli>\n\u003Cp>Cornell University | College of Agriculture and Life Sciences | Ithaca, NY\nBachelor of Science in Biology, Concentration in Computational Biology, 2010-2014\u003C/p>\n\u003C/li>\n\u003C/ul>\n\u003Ch2 id=\"skills-and-expertise\">Skills and Expertise\u003C/h2>\n\u003Cul>\n\u003Cli>Workflow development: published ChIP-seq methods, experience with Github, Docker, conda, Nextflow, Snakemake\u003C/li>\n\u003Cli>Programming languages: Unix/Linux, Python, R programming, command line, git, SQL, Apache spark, Matlab, Perl, and Java\u003C/li>\n\u003Cli>Genomics software: BWA, Bowtie, Bowtie2, STAR, kallisto, MACS2, UMAP, Blacklist, DiffBind, DESeq2, EdgeR, sleuth,\nDANPOS2, DANPOS3, FASTQC, bedtools, samtools, deeptools, MEME, HOMER, AHA, PBJelly, miRDeep2, miRDeep*, miREAP,\nmiRdentify, Centroidfold, CAP-miRSeq\u003C/li>\n\u003Cli>Databases: UK Biobank, gnomAD, GTex, ClinVar, dbNSFP, Clingen, Genebass, dbSNP\u003C/li>\n\u003Cli>Genetics software: PLINK, VCFtools, bcftools, VEP, LOFTEE, MutPred2, ESM1b, AlphaMissense\u003C/li>\n\u003C/ul>\n\u003C!---\n\n## Innovation and Problem-Solving\n\nI thrive on solving complex problems and transforming ideas into functional, elegant websites. Whether it's optimizing performance, implementing new features, or troubleshooting issues, I approach each challenge with enthusiasm and a commitment to delivering high-quality solutions.\n\n## Global Perspective, Local Impact\n\nLiving in Estonia has not only influenced my appreciation for nature and culture but has also shaped my approach to web development. I understand the importance of creating digital solutions that resonate with local audiences while maintaining a global perspective.\n\n## Continuous Learning\n\nThe dynamic nature of the tech industry inspires me to stay up-to-date with the latest trends and advancements. I'm always eager to expand my skill set and embrace emerging technologies that enhance the functionality and aesthetics of the websites I create.\n\n## Collaboration and Communication\n\nI believe in the power of collaboration and effective communication. Whether working with clients, designers, or fellow developers, I value clear communication to ensure the success of every project.\n\n## Get in Touch\n\nAre you looking to elevate your online presence or bring your digital ideas to life? I'd love to hear from you! Feel free to reach out for collaboration, consultation, or just a friendly chat about all things web development.\n\n_Let's build something amazing together!_\n\n-->",{"headings":619,"localImagePaths":629,"remoteImagePaths":630,"frontmatter":631,"imagePaths":634},[620,623,626],{"depth":52,"slug":621,"text":622},"samantha-klasfeld---computational-biologist-currently-based-in-cambridge-ma","Samantha Klasfeld - Computational Biologist currently based in Cambridge, MA",{"depth":52,"slug":624,"text":625},"education","Education",{"depth":52,"slug":627,"text":628},"skills-and-expertise","Skills and Expertise",[],[],{"title":606,"seo":632},{"title":608,"description":609,"image":633},{"src":611,"alt":612},[]]